Get the Stockscreener App
3.81
1.80%
-0.07
Health Catalyst Inc stock is traded at $3.81, with a volume of 511.88K.
It is down -1.80% in the last 24 hours and down -6.16% over the past month.
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
See More
Previous Close:
$3.88
Open:
$3.71
24h Volume:
511.88K
Relative Volume:
0.89
Market Cap:
$288.15M
Revenue:
$299.48M
Net Income/Loss:
$-86.45M
P/E Ratio:
-2.54
EPS:
-1.5
Net Cash Flow:
$-17.32M
1W Performance:
-7.97%
1M Performance:
-6.16%
6M Performance:
-50.20%
1Y Performance:
-40.65%
1-Day Range:
$3.6152
$3.96
1-Week Range:
$3.6152
$4.20
52-Week Range:
$3.49
$9.24
Health Catalyst Inc Stock (HCAT) Company Profile
Name
Health Catalyst Inc
Sector
Industry
Phone
801-708-6800
Address
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Compare HCAT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HCAT
Health Catalyst Inc
|
3.81 | 288.15M | 299.48M | -86.45M | -17.32M | -1.50 |
|
VEEV
Veeva Systems Inc
|
281.89 | 46.43B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
70.11 | 12.01B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
58.51 | 11.00B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
100.01 | 9.27B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
38.33 | 7.03B | 906.14M | -52.62M | 89.62M | -0.3621 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-09-25 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-08-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Jan-03-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-13-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-13-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-01-23 | Initiated | Cantor Fitzgerald | Overweight |
| May-10-23 | Downgrade | Guggenheim | Buy → Neutral |
| May-10-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-20-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-12-23 | Initiated | Stephens | Equal-Weight |
| Apr-04-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-31-22 | Initiated | Wells Fargo | Equal Weight |
| Oct-25-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-13-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-05-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-05-22 | Downgrade | Stifel | Buy → Hold |
| Apr-14-22 | Initiated | Guggenheim | Buy |
| Mar-17-22 | Upgrade | Jefferies | Hold → Buy |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-02-21 | Initiated | Jefferies | Hold |
| Oct-14-21 | Initiated | BTIG Research | Buy |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Dec-08-20 | Initiated | Berenberg | Buy |
| Jul-14-20 | Initiated | Citigroup | Buy |
| Jun-18-20 | Initiated | Stifel | Buy |
| Jun-15-20 | Resumed | Evercore ISI | Outperform |
| May-15-20 | Initiated | Guggenheim | Buy |
| Apr-21-20 | Initiated | RBC Capital Mkts | Outperform |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Apr-02-20 | Initiated | Canaccord Genuity | Buy |
| Dec-20-19 | Initiated | Raymond James | Strong Buy |
| Oct-30-19 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-19-19 | Initiated | Evercore ISI | Outperform |
| Aug-19-19 | Initiated | Goldman | Buy |
| Aug-19-19 | Initiated | JP Morgan | Overweight |
| Aug-19-19 | Initiated | Piper Jaffray | Overweight |
| Aug-19-19 | Initiated | SVB Leerink | Outperform |
| Aug-19-19 | Initiated | SunTrust | Buy |
| Aug-19-19 | Initiated | William Blair | Outperform |
View All
Health Catalyst Inc Stock (HCAT) Latest News
Health Catalyst stock downgraded by BTIG on healthcare coverage concerns - Investing.com
Health Catalyst (HCAT) Faces Downgrade Amid Financial Pressures - GuruFocus
Data Analytics Stocks Q1 Teardown: Health Catalyst (NASDAQ:HCAT) Vs The Rest - Yahoo Finance
BTIG Downgrades Health Catalyst to Neutral From Buy - marketscreener.com
Health Catalyst’s SWOT analysis: data analytics firm navigates healthcare shifts - Investing.com Nigeria
(HCAT) Technical Data - news.stocktradersdaily.com
HCAT Q1 Earnings Call: Ignite Platform Drives Client Growth Amid Funding Uncertainty - Yahoo Finance
Health Catalyst: Ignite Platform Is A Growth Catalyst (NASDAQ:HCAT) - Seeking Alpha
Stifel maintains Health Catalyst stock Hold rating, $5.50 target By Investing.com - Investing.com South Africa
Stifel maintains Health Catalyst stock Hold rating, $5.50 target - Investing.com Australia
Health Catalyst, Steven Madden, Astronics, Wayfair, and Robinhood Shares Are Soaring, What You Need To Know - Yahoo Finance
Deutsche Bank AG Acquires 19,659 Shares of Health Catalyst, Inc. (NASDAQ:HCAT) - Defense World
Health catalyst sees 10% technology revenue growth in Q1 2025 amid Ignite platform adoption - MSN
Health Catalyst stock hits 52-week low at $3.54 amid market challenges - Investing.com Australia
Health Catalyst stock hits 52-week low at $3.54 amid market challenges By Investing.com - Investing.com South Africa
BNP Paribas Financial Markets Makes New Investment in Health Catalyst, Inc. (NASDAQ:HCAT) - Defense World
Health Catalyst’s SWOT analysis: ignite platform fuels stock growth hopes By Investing.com - Investing.com Nigeria
Northern Trust Corp Acquires 41,298 Shares of Health Catalyst, Inc. (NASDAQ:HCAT) - Defense World
Health Catalyst’s SWOT analysis: ignite platform fuels stock growth hopes - Investing.com Australia
Health Catalyst to Participate in Upcoming Investor Conferences - The Manila Times
Learn to Evaluate (HCAT) using the Charts - news.stocktradersdaily.com
1 Mooning Stock Worth Your Attention and 2 to Avoid - Yahoo Finance
Health Catalyst (NASDAQ:HCAT) Price Target Raised to $5.50 - Defense World
Dimensional Fund Advisors LP Increases Stake in Health Catalyst, Inc. (NASDAQ:HCAT) - Defense World
Health Catalyst, Inc. (NASDAQ:HCAT) Q1 2025 Earnings Call Transcript - Insider Monkey
Health Catalyst, Inc. (NASDAQ:HCAT) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates - simplywall.st
Health Catalyst First Quarter 2025 Earnings: EPS Misses Expectations - Yahoo Finance
Health Catalyst (HCAT): Analyst Maintains Buy Rating, Lowers Price Target | HCAT Stock News - GuruFocus
Envestnet Asset Management Inc. Purchases 16,208 Shares of Health Catalyst, Inc. (NASDAQ:HCAT) - Defense World
Health Catalyst (HCAT) Target Price Raised by Stifel Analyst | H - GuruFocus
Health Catalyst (HCAT) Target Price Raised by Stifel Analyst | HCAT Stock News - GuruFocus
Breaking Down Health Catalyst: 9 Analysts Share Their Views - Benzinga
Evercore ISI lifts Health Catalyst stock to $5 target By Investing.com - Investing.com South Africa
Canaccord cuts Health Catalyst price target to $9, maintains buy By Investing.com - Investing.com Australia
Canaccord Adjusts Price Target for Health Catalyst (HCAT), Remai - GuruFocus
Canaccord cuts Health Catalyst price target to $9, maintains buy - Investing.com
Canaccord Adjusts Price Target for Health Catalyst (HCAT), Remains Optimistic | HCAT Stock News - GuruFocus
Evercore ISI lifts Health Catalyst stock to $5 target - Investing.com Australia
Detailed Analysis of Population Based Health Services Market | - openPR.com
Health Catalyst: Q1 Earnings Snapshot - The Washington Post
Health Catalyst (HCAT) Surpasses Q1 Revenue and Earnings Projections | HCAT Stock News - GuruFocus
Health Catalyst Inc Reports Q1 2025 Earnings: EPS of -$0.35 Miss - GuruFocus
Health Catalyst (HCAT) Projects FY25 Adjusted EBITDA of $41 Mill - GuruFocus
Health Catalyst Inc Stock (HCAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.51%
4.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):